New Insights into Atrial Fibrillation

Dear colleagues,

Current medicine is rapidly growing. Advances in our knowledge of the scientific and clinical aspects of atrial fibrillation (AF) have enabled progress in AF treatment. This fact is of particularimportance because AF constitutes the most common arrhythmia; its prevalence has risen to epidemic levels worldwide and will grow over the next decades. The public health dimension of AF underlines the recognition of AF risk factors as well as AF prediction and management.

The scientfic and clinical aspects of AF involve both targeted prevention programs and the current developments in diagnosis, monitoring and treatment, including current technological and methodological advances.

Novel diagnostic tools offer insight into AF diagnosis, AF burden, atrial cardiomyopathy and thromboembolic risk. Rhythm control or rate control and stroke prophylaxis are the cornerstones of AF therapy; however, all these strategies have been constantly improved evolution. Because of the limited efficacy of antiarrhythmic drugs for risk factors’ modification, “up-stream” therapy and AF ablation have become primary therapeutic strategies. Pulmonary vein isolation is the main but not only form of AF ablation. Several new ablation techniques and technologies and stroke prophylaxes are being explored. New conceptional and technological evolution (e.g., eHealth and artificial inteligence) promises an exciting future in the development of complex AF approaches.

In this Special Issue, we invite researchers to submit high-quality original papers on new insights into the prevalence, pathophysiology, diagnosis, monitoring, risk prediction, prophylaxis and treatment options of AF.

Prof. Dr. Katarzyna Mizia-Stec
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.